Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Publications

Search Items: CIRCULATING TUMOR CELLS, . hits: 54

2020

Hofmann, L; Kroneis, T; El-Heliebi, A Using In Situ Padlock Probe Technology to Detect mRNA Splice Variants in Tumor Cells.
Methods Mol Biol. 2020; 2148:361-378
PubMed FullText FullText_MUG

 

Koch, C; Kuske, A; Joosse, SA; Yigit, G; Sflomos, G; Thaler, S; Smit, DJ; Werner, S; Borgmann, K; Gartner, S; Mohammadi, PM; Battista, L; Cayrefourcq, L; Altmuller, J; Salinas-Riester, G; Raithatha, K; Zibat, A; Goy, Y; Ott, L; Bartkowiak, K; Tan, TZ; Zhou, Q; Speicher, MR; Muller, V; Gorges, TM; Jucker, M; Thiery, JP; Brisken, C; Riethdorf, S; Alix-Panabieres, C; Pantel, K Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
EMBO MOL MED. 2020; e11908
Web of Science PubMed FullText FullText_MUG

 

2019

Chen, S; Tauber, G; Langsenlehner, T; Schmölzer, LM; Pötscher, M; Riethdorf, S; Kuske, A; Leitinger, G; Kashofer, K; Czyż, ZT; Polzer, B; Pantel, K; Sedlmayr, P; Kroneis, T; El-Heliebi, A In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy.
Cancers (Basel). 2019; 11(7): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dahlem, C; Barghash, A; Puchas, P; Haybaeck, J; Kessler, SM The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer.
Int J Mol Sci. 2019; 20(13): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

de Wit, S; Rossi, E; Weber, S; Tamminga, M; Manicone, M; Swennenhuis, JF; Groothuis-Oudshoorn, CGM; Vidotto, R; Facchinetti, A; Zeune, LL; Schuuring, E; Zamarchi, R; Hiltermann, TJN; Speicher, MR; Heitzer, E; Terstappen, LWMM; Groen, HJM Single tube liquid biopsy for advanced non-small cell lung cancer.
Int J Cancer. 2019; 144(12): 3127-3137. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Marcuello, M; Vymetalkova, V; Neves, RPL; Duran-Sanchon, S; Vedeld, HM; Tham, E; van Dalum, G; Flugen, G; Garcia-Barberan, V; Fijneman, RJ; Castells, A; Vodicka, P; Lind, GE; Stoecklein, NH; Heitzer, E; Gironella, M Circulating biomarkers for early detection and clinical management of colorectal cancer
MOL ASPECTS MED. 2019; 69: 107-122. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riethdorf, S; Hildebrandt, L; Heinzerling, L; Heitzer, E; Fischer, N; Bergmann, S; Mauermann, O; Waldispühl-Geigl, J; Coith, C; Schön, G; Peine, S; Schuler, G; Speicher, MR; Moll, I; Pantel, K Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma.
CLIN CHEM. 2019; 65(3): 462-472.
Web of Science PubMed FullText FullText_MUG

 

Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Trapp, E; Janni, W; Schindlbeck, C; Jückstock, J; Andergassen, U; de Gregorio, A; Alunni-Fabbroni, M; Tzschaschel, M; Polasik, A; Koch, JG; Friedl, TWP; Fasching, PA; Haeberle, L; Fehm, T; Schneeweiss, A; Beckmann, MW; Pantel, K; Mueller, V; Rack, B; Scholz, C; SUCCESS Study Group Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
J Natl Cancer Inst. 2019; 111(4):380-387
Web of Science PubMed FullText FullText_MUG

 

2018

Agarwal, A; Balic, M; El-Ashry, D; Cote, RJ Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.
Cancer J. 2018; 24(2):70-77 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Alunni-Fabbroni, M; Majunke, L; Trapp, EK; Tzschaschel, M; Mahner, S; Fasching, PA; Fehm, T; Schneeweiss, A; Beck, T; Lorenz, R; Friedl, TWP; Janni, W; Rack, B; SUCCESS Study Group Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
BMC Cancer. 2018; 18(1):141-141 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Chen, S; El-Heliebi, A; Schmid, J; Kashofer, K; Czyż, ZT; Polzer, BM; Pantel, K; Kroneis, T; Sedlmayr, P Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization.
J Vis Exp. 2018; (135): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

de Wit, S; Manicone, M; Rossi, E; Lampignano, R; Yang, L; Zill, B; Rengel-Puertas, A; Ouhlen, M; Crespo, M; Berghuis, AMS; Andree, KC; Vidotto, R; Trapp, EK; Tzschaschel, M; Colomba, E; Fowler, G; Flohr, P; Rescigno, P; Fontes, MS; Zamarchi, R; Fehm, T; Neubauer, H; Rack, B; Alunni-Fabbroni, M; Farace, F; De Bono, J; IJzerman, MJ; Terstappen, LWMM EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.
Oncotarget. 2018; 9(86):35705-35716 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

El-Heliebi, A; Hille, C; Laxman, N; Svedlund, J; Haudum, C; Ercan, E; Kroneis, T; Chen, S; Smolle, M; Rossmann, C; Krzywkowski, T; Ahlford, A; Darai, E; von Amsberg, G; Alsdorf, W; König, F; Löhr, M; de Kruijff, I; Riethdorf, S; Gorges, TM; Pantel, K; Bauernhofer, T; Nilsson, M; Sedlmayr, P In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells.
Clin Chem. 2018; 64(3):536-546 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Markou, A; Lazaridou, M; Paraskevopoulos, P; Chen, S; Świerczewska, M; Budna, J; Kuske, A; Gorges, TM; Joosse, SA; Kroneis, T; Zabel, M; Sedlmayr, P; Alix-Panabières, C; Pantel, K; Lianidou, ES Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.
Clin Chem. 2018; 64(2):297-306 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schochter, F; Rack, B; Tzschaschel, M; Polasik, A; Andergassen, U; Trapp, E; Alunni-Fabbroni, M; Schneeweiss, A; Müller, V; Pantel, K; Gade, J; Lorenz, R; Rezai, M; Tesch, H; Soeling, U; Fehm, T; Mahner, S; Schindlbeck, C; Lichtenegger, W; Beckmann, MW; Fasching, PA; Janni, W; Friedl, TWP; SUCCESS Study Group Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
Oncol Res Treat. 2018; 41(3):93-98 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Benezeder, T; Tiran, V; Treitler, AAN; Suppan, C; Rossmann, C; Stoeger, H; Cote, RJ; Datar, RH; Balic, M; Dandachi, N Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.
Oncotarget. 2017; 8(54):92483-92496 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Chen, S; El-Heliebi, A; Kroneis, T Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine?
Adv Clin Chem. 2017; 82(6):71-103
Web of Science PubMed FullText FullText_MUG

 

Dandachi, N; Tiran, V; Lindenmann, J; Brcic, L; Fink-Neuboeck, N; Kashofer, K; Absenger, G; Bezan, A; Cote, RJ; Datar, R; Balic, M Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Lung Cancer. 2017; 113(46):152-157
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Perakis, S; Geigl, JB; Speicher, MR The potential of liquid biopsies for the early detection of cancer.
NPJ Precis Oncol. 2017; 1(1):36-36 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Perakis, S; Speicher, MR Emerging concepts in liquid biopsies.
BMC Med. 2017; 15(1):75-75 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285
Web of Science PubMed FullText FullText_MUG

 

Suppan, C; Balic, M Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016.
Memo. 2017; 10(2):82-85 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Trapp, EK; Majunke, L; Zill, B; Sommer, H; Andergassen, U; Koch, J; Harbeck, N; Mahner, S; Friedl, TWP; Janni, W; Rack, B; Alunni-Fabbroni, M LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Mol Oncol. 2017; 11(11):1508-1526 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ulz, P; Heitzer, E; Geigl, JB; Speicher, MR Patient monitoring through liquid biopsies using circulating tumor DNA.
Int J Cancer. 2017; 141(5):887-896 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Heitzer, E; Ulz, P; Geigl, JB; Speicher, MR Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies.
Mol Oncol. 2016; 10(3):494-502 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hepp, P; Andergassen, U; Jäger, B; Trapp, E; Alunni-Fabbroni, M; Friedl, TW; Hecker, N; Lorenz, R; Fasching, P; Schneeweiss, A; Fehm, T; Janni, W; Rack, B Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
Anticancer Res. 2016; 36(9):4771-4776
Web of Science PubMed FullText FullText_MUG

 

Hofman, P; Popper, HH Pathologists and liquid biopsies: to be or not to be?
Virchows Arch. 2016; 469(6):601-609
Web of Science PubMed FullText FullText_MUG

 

Jueckstock, J; Rack, B; Friedl, TW; Scholz, C; Steidl, J; Trapp, E; Tesch, H; Forstbauer, H; Lorenz, R; Rezai, M; Häberle, L; Alunni-Fabbroni, M; Schneeweiss, A; Beckmann, MW; Lichtenegger, W; Fasching, PA; Pantel, K; Janni, W; SUCCESS Study Group Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
BMC Cancer. 2016; 16(10):401-401 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

König, A; Vilsmaier, T; Rack, B; Friese, K; Janni, W; Jeschke, U; Andergassen, U; Trapp, E; Jückstock, J; Jäger, B; Alunni-Fabbroni, M; Friedl, T; Weissenbacher, T; SUCCESS STUDY GROUP Determination of Interleukin-4, -5, -6, -8 and -13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
Anticancer Res. 2016; 36(6):3123-3130
Web of Science PubMed

 

Pantel, K; Speicher, MR The biology of circulating tumor cells.
Oncogene. 2016; 35(10):1216-1224
Web of Science PubMed FullText FullText_MUG

 

Rack, B; Zombirt, E; Trapp, E; Jückstock, J; Andergassen, U; Neugebauer, J; Kost, B; Weissenbacher, T; Jeschke, U; Schindlbeck, C; Janni, W; Alunni-Fabbroni, M Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
Oncology. 2016; 90(4):232-238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281
Web of Science PubMed FullText FullText_MUG

 

Speicher, MR; Gerger, A; Hoefler, G Liquid biopsies. A multidisciplinary challenge for human geneticists, oncologists, and pathologists
MED GENET-BERLIN. 2016; 28(2): 245-250. [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Dorner, N; Kühs, U; Aufderklamm, S; Rausch, S; Bier, S; Mischinger, J; Schellbach, D; Hauch, S; Feniuk, N; Bedke, J; Gakis, G; Stenzl, A; Schwentner, C Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
J Cancer Res Clin Oncol. 2016; 142(5):1013-1020
Web of Science PubMed FullText FullText_MUG

 

Ulz, P; Geigl, JB; Speicher, MR; Heitzer, E Latest technological developments in the analysis of circulating tumor DNA
MED GENET-BERLIN. 2016; 28(2): 234-244. [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

2014

Heidary, M; Auer, M; Ulz, P; Heitzer, E; Petru, E; Gasch, C; Riethdorf, S; Mauermann, O; Lafer, I; Pristauz, G; Lax, S; Pantel, K; Geigl, JB; Speicher, MR The dynamic range of circulating tumor DNA in metastatic breast cancer.
Breast Cancer Res. 2014; 16(4):421-421 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Müller, C; Holtschmidt, J; Auer, M; Heitzer, E; Lamszus, K; Schulte, A; Matschke, J; Langer-Freitag, S; Gasch, C; Stoupiec, M; Mauermann, O; Peine, S; Glatzel, M; Speicher, MR; Geigl, JB; Westphal, M; Pantel, K; Riethdorf, S Hematogenous dissemination of glioblastoma multiforme.
Sci Transl Med. 2014; 6(247):247ra101-247ra101 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Balic, M; Williams, A; Lin, H; Datar, R; Cote, RJ Circulating Tumor Cells: From Bench to Bedside.
Annu Rev Med. 2013; 64(7):31-44 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

El-Heliebi, A; Kroneis, T; Zöhrer, E; Haybaeck, J; Fischereder, K; Kampel-Kettner, K; Zigeuner, R; Pock, H; Riedl, R; Stauber, R; Geigl, JB; Huppertz, B; Sedlmayr, P; Lackner, C Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
J Transl Med. 2013; 11(10):214-214 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Heitzer, E; Auer, M; Gasch, C; Pichler, M; Ulz, P; Hoffmann, EM; Lax, S; Waldispuehl-Geigl, J; Mauermann, O; Lackner, C; Höfler, G; Eisner, F; Sill, H; Samonigg, H; Pantel, K; Riethdorf, S; Bauernhofer, T; Geigl, JB; Speicher, MR Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.
Cancer Res. 2013; 73(10):2965-2975 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Heitzer, E; Auer, M; Ulz, P; Geigl, JB; Speicher, MR Circulating tumor cells and DNA as liquid biopsies.
Genome Med. 2013; 5(8):73-73 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Balic, M; Lin, H; Williams, A; Datar, RH; Cote, RJ Progress in circulating tumor cell capture and analysis: implications for cancer management.
Expert Rev Mol Diagn. 2012; 12(3):303-312 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mathiesen, RR; Fjelldal, R; Liestl, K; Due, EU; Geigl, JB; Riethdorf, S; Borgen, E; Rye, IH; Schneider, IJ; Obenauf, AC; Mauermann, O; Nilsen, G; Christian Lingjaerde, O; Brresen-Dale, AL; Pantel, K; Speicher, MR; Naume, B; Baumbusch, LO High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.
Int J Cancer. 2012; 131(4):E405-E415 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Feyerabend, S; Aufderklamm, S; Mischinger, J; Kühs, U; Gerber, V; Fetisch, J; Schilling, D; Hauch, S; Stenzl, A; Schwentner, C Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients.
Anticancer Res. 2012; 32(8):3507-3513
Web of Science PubMed

 

Williams, A; Balic, M; Datar, R; Cote, R Size-based enrichment technologies for CTC detection and characterization.
Recent Results Cancer Res. 2012; 195: 87-95.
PubMed FullText FullText_MUG

 

2011

Lin, H; Balic, M; Zheng, S; Datar, R; Cote, RJ Disseminated and circulating tumor cells: Role in effective cancer management.
Crit Rev Oncol Hematol. 2011; 77(1):1-11
Web of Science PubMed FullText FullText_MUG

 

2010

Balic, M; Williams, A; Dandachi, N; Cote, RJ Micrometastasis: detection methods and clinical importance.
Cancer Biomark. 2010; 9(1-6):397-419
Web of Science PubMed FullText FullText_MUG

 

2008

Stanzer, S; Dandachi, N; Balic, M; Resel, M; Samonigg, H; Bauernhofer, T Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.
J Clin Immunol. 2008; 28(2):107-114
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Zheng, S; Lin, H; Liu, JQ; Balic, M; Datar, R; Cote, RJ; Tai, YC Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
J Chromatogr A. 2007; 1162(2):154-161
Web of Science PubMed FullText FullText_MUG

 

Show the next 50 results of search
© Med Uni GrazImprint